Anna Sundlov
Lund, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Patient Survival and Its Relation to Tumor Absorbed Dose in [177Lu]Lu-DOTATATE Therapy of Neuroendocrine Tumors.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 07, 2025
Molecular-clinical characteristics and treatment outcomes in 163 metastatic colorectal neuroendocrine carcinomas with a comparison to colorectal adenocarcinomas.
Journal: International journal of cancer
Published: September 10, 2025
Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study.
Journal: British journal of cancer
Published: July 14, 2025
Quality of life as a predictor for survival in patients with small intestinal neuroendocrine tumours.
Journal: Journal of neuroendocrinology
Published: May 15, 2025
Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study.
Journal: British journal of cancer
Published: January 27, 2025
Retrospective evaluation of the predictive value of tumour burden at baseline [68 Ga]Ga-DOTA-TOC or -TATE PET/CT and tumour dosimetry in GEP-NET patients treated with PRRT.
Journal: EJNMMI reports
Published: April 18, 2024
NETest in advanced high-grade gastroenteropancreatic neuroendocrine neoplasms.
Journal: Journal of neuroendocrinology
Published: January 19, 2024
Relationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 16, 2023
Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms.
Journal: British journal of cancer
Published: June 19, 2023
Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.
Journal: Acta oncologica (Stockholm, Sweden)
Published: May 17, 2023
AI-based quantification of whole-body tumour burden on somatostatin receptor PET/CT.
Journal: European journal of hybrid imaging
Published: May 11, 2023
Optimal follow-up with somatostatin receptor PET/CT imaging in patients with small intestinal neuroendocrine tumours.
Journal: Journal of neuroendocrinology
Published: March 24, 2023
Last Updated: 09/26/2026